826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of heal...

by Vartan Pahalyants, Nikolai Klebanov, Nicholas Theodosakis, Monina Klevens, Evelyn Lilly, Yevgeniy Semenov
Published 2020-11-01

855 Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses

by Shannon Wongvibulsin, Jarushka Naidoo, Yevgeniy Semenov, Shawn Kwatra, Thomas Le, Subuhi Kaul, Laura Cappelli
Published 2020-11-01

854 Prediction of severe immune-related adverse events in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the United States

by Kun-Hsing Yu, Shannon Wongvibulsin, Vartan Pahalyants, Yevgeniy Semenov, Mark Kalinich, Feicheng Wang, Vivek Naranbhai, Alexander Gusev, Shawn Kwatra
Published 2020-11-01

Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center

by Micah Belzberg, Valerie A. Larson, Raveena Khanna, Kyle A. Williams, Yevgeniy Semenov, Sonja Ständer, Anna L. Grossberg, Shawn G. Kwatra
Published 2019-10-01